APOE and Alzheimer disease: Recently, Fitz et al., using preclinical AD mouse models, demonstrated that APOE3 lipoproteins, compared to APOE4, prompted faster microglial migration toward injected Aβ, facilitated Aβ uptake, and abrogated damaging effects of Aβ oligomers on cognition (Fitz et al., 2021).